StageUnattributed - II | Alive
Last Raised$1M | 5 yrs ago
Missing: Xios Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Xios Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Xios Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Xios Therapeutics is included in 2 Expert Collections, including Biopharma Tech.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Xios Therapeutics Frequently Asked Questions (FAQ)
When was Xios Therapeutics founded?
Xios Therapeutics was founded in 2015.
Where is Xios Therapeutics's headquarters?
Xios Therapeutics's headquarters is located at 100 Beaver Street, Waltham.
What is Xios Therapeutics's latest funding round?
Xios Therapeutics's latest funding round is Unattributed - II.
How much did Xios Therapeutics raise?
Xios Therapeutics raised a total of $7M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.